The molecular evolution of melanoma distant metastases.

Melanoma allele frequency copy number metastasis targeted therapy

Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
04 Apr 2024
Historique:
received: 19 12 2023
revised: 26 02 2024
accepted: 14 03 2024
medline: 7 4 2024
pubmed: 7 4 2024
entrez: 6 4 2024
Statut: aheadofprint

Résumé

The evolution of primary melanoma to lymph node and distant metastasis is incompletely understood. We examined the genomic diversity in melanoma progression in matched primary melanomas, lymph node and distant metastases from 17 patients. Fluorescence in situ hybridization (FISH) analysis revealed cancer cell fractions with monotonic copy number alterations (CNAs), including PHIP gain and PTEN loss, in the metastatic cascade. By contrast, the cancer cell fraction with CNAs for BPTF and MITF was reduced in lymph node metastases but increased in distant metastases. Separately, the cancer cell fraction with NCOA3 CNA was comparable in primary tumors and lymph nodes yet increased in distant metastases. These results suggest enrichment of the PI3K and MITF pathways in the transition through the metastatic cascade. By contrast, next-generation sequencing analysis did not identify a consistent pattern of changes in variant allele frequency (VAF) while revealing several intriguing findings, including decreased VAF in distant metastases and distinct drivers in lymph node versus distant metastases. These results provide evidence that distant melanoma metastasis does not always emanate from lymph node metastasis. These results enhance our understanding of clonal patterns of melanoma metastasis, with possible implications for targeted therapy and metastasis competency.

Identifiants

pubmed: 38582370
pii: S0022-202X(24)00271-9
doi: 10.1016/j.jid.2024.03.029
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Vladimir Bezrookove (V)

Center for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) and; CPMC Research Institute, San Francisco, CA.

Sara Kianian (S)

Center for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) and; CPMC Research Institute, San Francisco, CA.

Lea McGeever (L)

CPMC Research Institute, San Francisco, CA.

Robyn Jones (R)

CPMC Research Institute, San Francisco, CA.

Chongshan Caressi (C)

Center for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) and; CPMC Research Institute, San Francisco, CA.

Mehdi Nosrati (M)

Center for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) and; CPMC Research Institute, San Francisco, CA.

Kevin B Kim (KB)

Center for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) and; CPMC Research Institute, San Francisco, CA.

Stanley P Leong (SP)

Center for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) and; CPMC Research Institute, San Francisco, CA.

James R Miller (JR)

Center for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) and; CPMC Research Institute, San Francisco, CA.

Pierre-Yves Desprez (PY)

CPMC Research Institute, San Francisco, CA.

Mohammed Kashani-Sabet (M)

Center for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) and; CPMC Research Institute, San Francisco, CA. Electronic address: kashani@cpmcri.org.

Classifications MeSH